New York, United States, July 12, 2022 (GLOBE NEWSWIRE) — The rising number of infectious disease and cancer patients, the global population that is rapidly ageing and increased automation in the field of medicine are the primary drivers of the market.
Insights into the Immunoassay Market:
- By Type or Platform, Enzyme Immunoassays dominated the market.
- By Technique, the enzyme-linked immunosorbent assay (ELISA) leads the market.
- By Application, the infectious diseases segment held the highest market share.
- By Product Type, Reagents and kits dominated the market.
- By End Users, hospitals held the highest share.
- By Specimen, blood had the leading share of the market.
- By region, North America dominated the market.
To get a first-hand overview of the report, Request a Sample at
https://www.strategicmarketresearch.com/request-sample/immunoassay-market
Factors behind rapid market growth:
A rise in the number of infectious diseases:
Infectious diseases are those diseases which are primarily caused by micro-organisms like bacteria, fungi, viruses and parasites. There has been a rising number of infectious diseases across the globe due to rapid urbanization coupled with exponential deforestation. According to the CDC, over 3 million primary diagnoses in Emergency Rooms are either infectious or parasitic diseases, and at the doctor’s offices, the number rises to above 7 million. According to the WHO, over 17 million people die of infectious diseases. Therefore, with the…
